ProfileGDS4718 / 218576_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 77% 83% 80% 79% 84% 82% 79% 75% 80% 81% 78% 82% 84% 80% 81% 80% 81% 83% 81% 79% 81% 79% 80% 79% 83% 82% 80% 77% 82% 82% 85% 77% 75% 87% 88% 83% 80% 79% 87% 80% 79% 80% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.7530879
GSM549102patient 115, normal, homogenized [OPG study]7.4207477
GSM549104patient 119, normal, homogenized [OPG study]8.2280783
GSM549108patient 138, normal, homogenized [OPG study]7.8035580
GSM549119patient 077, normal, homogenized [OPG study]7.7293779
GSM549133patient 032, cancer, homogenized [OPG study]8.520284
GSM549139patient 042, cancer, homogenized [OPG study]8.1324382
GSM549099patient 107, normal, homogenized [OPG study]7.6499779
GSM549109patient 139, normal, homogenized [OPG study]7.2736175
GSM549110patient 046, normal, homogenized [OPG study]7.8115980
GSM549114patient 063, normal, homogenized [OPG study]8.0107781
GSM549122patient 082, normal, homogenized [OPG study]7.6757578
GSM549134patient 033, cancer, homogenized [OPG study]8.0865582
GSM549136patient 036, cancer, homogenized [OPG study]8.3688784
GSM549140patient 044, cancer, homogenized [OPG study]7.9877480
GSM549111patient 047, normal, homogenized [OPG study]8.0480381
GSM549113patient 057, normal, homogenized [OPG study]7.984280
GSM549132patient 031, cancer, homogenized [OPG study]7.9796781
GSM549137patient 038, cancer, homogenized [OPG study]8.2766883
GSM549142patient 047, cancer, homogenized [OPG study]7.6826581
GSM549100patient 110, normal, homogenized [OPG study]7.6156179
GSM549107patient 135, normal, homogenized [OPG study]7.9975981
GSM549115patient 068, normal, homogenized [OPG study]7.8274179
GSM549116patient 072, normal, homogenized [OPG study]7.8910980
GSM549120patient 078, normal, homogenized [OPG study]7.7383779
GSM549131patient 030, cancer, homogenized [OPG study]8.3602883
GSM549118patient 074, normal, homogenized [OPG study]8.1747382
GSM549129patient 027, cancer, homogenized [OPG study]7.9189180
GSM549123patient 088, normal, homogenized [OPG study]7.5120677
GSM549124patient 006, cancer, homogenized [OPG study]8.0102182
GSM549126patient 015, cancer, homogenized [OPG study]8.0656482
GSM549128patient 025, cancer, homogenized [OPG study]8.5243785
GSM549103patient 117, normal, homogenized [OPG study]7.4129477
GSM549117patient 073, normal, homogenized [OPG study]7.3268475
GSM549138patient 041, cancer, homogenized [OPG study]8.7039487
GSM549141patient 045, cancer, homogenized [OPG study]8.9711488
GSM549130patient 028, cancer, homogenized [OPG study]8.173283
GSM549101patient 111, normal, homogenized [OPG study]7.8030180
GSM549105patient 128, normal, homogenized [OPG study]7.6824179
GSM549106patient 134, normal, homogenized [OPG study]8.8595287
GSM549112patient 048, normal, homogenized [OPG study]7.8289180
GSM549125patient 011, cancer, homogenized [OPG study]7.6812879
GSM549127patient 024, cancer, homogenized [OPG study]7.8641780
GSM549135patient 035, cancer, homogenized [OPG study]8.7452986